Join the Oxycodone group to help and get support from people like you.
Oxycodone News (Page 2)
Prevalence of Recreational Drug Use 11 Percent in Cardiac ICUs
FRIDAY, Aug. 18, 2023 – For patients hospitalized in intensive cardiac care units (ICCUs), the prevalence of recreational drug use is 11 percent, according to a study published online Aug. 15 in...
Most People Initiating Opioid Rx Have Very Low Use Trajectory
MONDAY, Aug. 14, 2023 – Most adults initiating treatment with prescription opioids have relatively low and time-limited exposure to opioids during a five-year period, according to a study published...
After U.S. Warns of Counterfeit Pills Laced With Fentanyl, Mexico Shuts Down 23 Pharmacies
WEDNESDAY, Aug. 9, 2023 – Following a four-day raid, Mexico has closed 23 pharmacies in Caribbean resorts of Cancun, Playa del Carmen and Tulum for irregular pill sales. Last spring, the United...
Just 1 in 5 Americans Struggling With Opioid Misuse Gets Meds That Can Help
MONDAY, Aug. 7, 2023 – The U.S. opioid abuse epidemic wages on, and overdose deaths continue to rise, yet just 1 in 5 people receives potentially lifesaving medication such as methadone,...
Oxycodone Does Not Increase Risk for Persistent Opioid Use After Delivery
MONDAY, July 31, 2023 – Initiation of oxycodone versus codeine is not associated with an increased risk for persistent opioid use after delivery overall, but increased risk is seen after vaginal...
More Rapid Increase Seen in Rate of OD Deaths Involving Cocaine + Opioids
WEDNESDAY, July 19, 2023 – The age-adjusted rate of overdose deaths involving cocaine and opioids increased more quickly from 2011 to 2021 than the rate of overdose deaths involving cocaine alone,...
New Opioid Use Raises Death Risk 11-Fold in Those With Dementia
TUESDAY, July 18, 2023 – Older adults who begin using opioid painkillers after a dementia diagnosis have a significantly greater risk of death — about 11-fold within the first two weeks, according t...
Access to Medical Marijuana Won't Lower Use of Opioid Painkillers: Study
WEDNESDAY, July 5, 2023 – Medical marijuana is touted as a pain reliever, but in U.S. states where it's legal, prescriptions for opioid or non-opioid painkillers haven't decreased, a new study...
FDA Medwatch Alert: Drug Safety Communication: All Opioid Pain Medicines - FDA Updates Prescribing Information to Provide Additional Guidance for Safe Use
ISSUE: The FDA is requiring several updates to the prescribing information for both immediate-release (IR) and extended release/long acting (ER/LA) opioid pain medicines. This includes stating for a...
Inspirion Delivery Sciences Receives FDA Approval for RoxyBond (oxycodone hydrochloride) Immediate Release Tablets with Abuse-Deterrent Label Claims
BASKING RIDGE, N.J., April 26, 2017 /PRNewswire/ – Inspirion Delivery Sciences, LLC ("Inspirion") announced that the United States Food and Drug Administration (FDA) has approved RoxyBond™ (...
FDA Approves Symproic (naldemedine) for the Treatment of Opioid-Induced Constipation
OSAKA, Japan and FLORHAM PARK, N.J. and STAMFORD, Conn., March 23, 2017 /PRNewswire/ – Shionogi Inc. and Purdue Pharma L.P. announced today that the U.S. Food and Drug Administration (FDA) approved...
Narcan (naloxone HCl) Nasal Spray 2mg Approved by U.S. Food and Drug Administration
January 25, 2017 – Dublin, Ireland – Today, the U.S. Food and Drug Administration (FDA) approved Narcan Nasal Spray as a 2mg formulation for the emergency treatment of known or suspected opioid ove...
FDA Medwatch Alert: Opioid Pain or Cough Medicines Combined With Benzodiazepines: Drug Safety Communication - FDA Requiring New Boxed Warnings About Serious Risks and Death
ISSUE: FDA review has found that the growing combined use of opioid medicines with benzodiazepines or other drugs that depress the central nervous system (CNS) has resulted in serious side effects,...
Collegium Receives FDA Approval for Xtampza ER, an Analgesic with Abuse-Deterrent Properties
CANTON, Mass., April 26, 2016 (GLOBE NEWSWIRE) – Collegium Pharmaceutical, Inc. (Nasdaq:COLL) today announced that the U.S. Food and Drug Administration (FDA) approved Xtampza ER (oxycodone)...
FDA Medwatch Alert: Opioid Pain Medicines: Drug Safety Communication - New Safety Warnings Added to Prescription Opioid Medications
ISSUE: FDA is warning about several safety issues with the entire class of opioid pain medicines. See the FDA Drug Safety Communication for a complete listing. These safety risks are potentially h...
Ask a question
To post your own question to this support group, sign in or create an account.